Shipping Information 06.10.2025 (Update 07.10. 12:40)

Update from 07.10. - 20:22

We have been able to process a very large number of orders and hand them over to DHL, but some will have to wait until tomorrow.


Update from 07.10. - 12:40

We will start with processing the next orders


Update from 07.10. - 02:55

Since October 6, 2025, at 11:30 AM, our team has been working around the clock to process the exceptionally high volume of incoming orders. Within just over 15 hours, we successfully packed and handed over the majority of orders to DHL. Many shipments are already on their way and will soon appear in DHL’s tracking system.

The remaining orders are currently in their final stage of processing and will be completed and handed over to DHL throughout October 7, 2025. We continue to process all orders strictly in the order in which they were received to ensure a fair and transparent workflow.

Since the founding of Remicals.de, our shipping volume has been steadily increasing – but what we’re experiencing right now exceeds all previous records. Compared to our previous peak, we’re currently handling roughly four times as many orders. This new milestone is a tremendous achievement for us and a clear sign of the growing trust our customers place in our shop and our work.

Despite the extremely high order volume, we remain fully committed to maintaining our quality standards. Every package is carefully checked, securely packed, and shipped discreetly. Our entire team is currently dedicating all available resources to packaging, shipping, and quality control to ensure smooth and reliable order fulfillment.

We want to express our sincere gratitude to all of you – for your trust, your patience, and your ongoing support. You are the reason why Remicals.de continues to grow, improve, and evolve. Every single order motivates us to keep pushing forward and give our very best.

Another update will follow later today once all remaining orders have been shipped.


Due to a very high volume of pre-orders and orders placed overnight and this morning, we cannot guarantee that all orders will be shipped today.

We are processing orders strictly in the order they were received. Please note that this may cause some delays.

Customer support is currently unavailable as our team is focused on packaging and shipping. For urgent inquiries, please reach us via email or the contact form. Response times may be longer than usual.

We will update this article throughout the day to keep you informed about our shipping progress.

Thank you for your patience and understanding!

This article is directly related to one or more of our products – for example, with regard to batches, availability, or quality updates.

We only provide such information via our news.

On the linked product page, you will find additional details about the product and can order or pre-order it directly there.

Available Soon Create Notification

With its dual action as a mu-opioid receptor agonist and norepinephrine reuptake inhibitor, O-DSMT HCL is a versatile research opioid.

The compound is primarily used in studies on tramadol metabolism, receptor affinity, and the absence of serotonergic activity, making it of interest for developing opioid-based substances with improved side effect profiles.

Our version of O-DSMT HCL is produced to the highest standards in a specialized partner laboratory and is laboratory-tested for high purity.

Available Immediately

IC-26 HCL, a structural analogue of methadone, acts as a mu-opioid receptor agonist and is used in research to explore structural modifications within the opioid class.

The substitution of the carbonyl group with a sulfonyl group makes IC-26 HCL particularly valuable for comparative analyses and studies on receptor binding and pharmacodynamics.

Our IC-26 HCL is synthesized exclusively through our partner laboratory, produced to a high-purity standard, and rigorously tested internally for identity and purity.

Available Immediately

SR-17018 HCL is a functionally selective mu-opioid receptor agonist that has attracted significant interest in preclinical research due to its innovative mechanism of action.

The compound is being studied for its potential to provide analgesia with a reduced incidence of typical opioid-related side effects and is suitable for studies on receptor binding dynamics, signal transduction, and biased agonism.

Our SR-17018 HCL is produced exclusively through our partner laboratory and stands out for its exceptionally high chemical purity and batch consistency.

Cookie Notice

We use cookies to offer you the best possible user experience. You can decide whether you only want to accept technically necessary cookies or also agree to the use of tracking cookies.

By clicking on "Accept all cookies" you agree to the use of all cookies.
If you only want to allow technically necessary cookies, select "Accept only necessary cookies".

You can find more information in our privacy policy.